When an asthma drug has an inferiority complex: a noninferiority trial.
Goodman
David C
DC
Department of Pediatrics and the Center for the Evaluative Clinical Sciences, Dartmouth Medical School, 7251 Strasenburgh Hall, Hanover, NH 03755, USA. david.goodman@dartmouth.edu
D000085:Acetates / Q000008:administration & dosage*; D000280:Administration, Inhalation; D000293:Adolescent; D000730:Androstadienes / Q000008:administration & dosage*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002648:Child; D003521:Cyclopropanes; D000068298:Fluticasone; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage*; D011804:Quinolines / Q000008:administration & dosage*; D012107:Research Design; D013440:Sulfides
D000085:Acetates; D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D000068298:Fluticasone; C093875:montelukast